Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2025 · 95 positions · Total reported value $1.74B · Top-10 concentration 36.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Rock Springs Capital Management LP disclosed 95 equity positions with a combined reported value of $1.74B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were ARGX ($104.02M), LLY ($93.74M), BPMC ($89.18M). By sector, the heaviest allocations are Health Care 80.6%, Consumer Discretionary 3.1%. Versus the prior quarter, allocation shifted toward Other (+2.7pp), Industrials (+0.7pp) and away from Consumer Staples (-1.9pp), Health Care (-1.9pp).

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 80% of names.

The largest new positions opened in Q1 2025 were DHR ($12.05M), MLYS ($5.09M), KMTS ($3.61M).

Of the 8 positions fully exited versus the prior quarter, the largest were FRPT ($48.51M), PODD ($29.83M), LFST ($18.79M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • DHR DANAHER CORP DEL · $12.05M
  • MLYS MINERALYS THERAPEUTICS INC · $5.09M
  • KMTS KESTRA MED TECHNOLOGIES LTD · $3.61M
  • REGN REGENERON PHARMACEUTICALS · $1.78M
  • AMLX AMYLYX PHARMACEUTICALS INC · $1.22M
  • SION SIONNA THERAPEUTICS INC · $1.04M

Fully Exited (vs previous quarter)

  • FRPT FRESHPET INC · prev qtr: $48.51M
  • PODD INSULET CORP · prev qtr: $29.83M
  • LFST LIFESTANCE HEALTH GROUP INC · prev qtr: $18.79M
  • CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $15.04M
  • SWTX SPRINGWORKS THERAPEUTICS INC · prev qtr: $11.88M
  • NMRA NEUMORA THERAPEUTICS INC. · prev qtr: $10.12M
  • XNCR XENCOR INC · prev qtr: $9.22M
  • BHVN BIOHAVEN LTD · prev qtr: $4.85M

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 80.6%
Technology 0.9%
Materials 0.0%
Other 14.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 175.75K $104.02M 5.97%
5.97%
Reduce
2 113.50K $93.74M 5.38%
5.38%
Reduce
3 1.01M $89.18M 5.12%
5.12%
Reduce
4 166.70K $55.22M 3.17%
3.17%
Reduce
5 100.50K $52.64M 3.02%
3.02%
Reduce
6 2.92M $52.35M 3.00%
3.00%
Reduce
7 102.00K $50.52M 2.90%
2.90%
Reduce
8 1.39M $50.49M 2.90%
2.90%
Reduce
9 171.00K $45.73M 2.62%
2.62%
Reduce
10 1.28M $45.32M 2.60%
2.60%
Add
11 834.19K $44.19M 2.54%
2.54%
Reduce
12 951.76K $42.88M 2.46%
2.46%
Reduce
13 980.75K $41.28M 2.37%
2.37%
Add
14 515.90K $39.36M 2.26%
2.26%
Reduce
15 143.25K $38.68M 2.22%
2.22%
Reduce
16 216.00K $33.67M 1.93%
1.93%
Reduce
17 904.59K $32.69M 1.88%
1.88%
Reduce
18 931.68K $31.26M 1.79%
1.79%
Reduce
19 279.00K $30.86M 1.77%
1.77%
Reduce
20 427.53K $30.32M 1.74%
1.74%
Reduce
21 6.95M $30.09M 1.73%
1.73%
Reduce
22 1.15M $29.35M 1.68%
1.68%
Reduce
23 277.00K $27.94M 1.60%
1.60%
Reduce
24 672.76K $27.23M 1.56%
1.56%
Reduce
25 397.65K $27.16M 1.56%
1.56%
Add
26 254.30K $26.62M 1.53%
1.53%
Reduce
27 2.70M $25.53M 1.47%
1.47%
Add
28 761.54K $24.48M 1.41%
1.41%
Add
29 794.44K $21.74M 1.25%
1.25%
Reduce
30 480.00K $20.78M 1.19%
1.19%
Add
31 681.10K $20.65M 1.19%
1.19%
Add
32 1.13M $19.61M 1.12%
1.12%
Add
33 995.00K $19.19M 1.10%
1.10%
Reduce
34 255.00K $18.48M 1.06%
1.06%
Reduce
35 354.38K $18.20M 1.04%
1.04%
Add
36 130.00K $17.48M 1.00%
1.00%
Add
37 512.93K $17.40M 1.00%
1.00%
Hold
38 975.80K $16.68M 0.96%
0.96%
Add
39 475.00K $16.45M 0.94%
0.94%
Hold
40 99.25K $15.81M 0.91%
0.91%
Reduce
41 1.91M $15.58M 0.89%
0.89%
Reduce
42 835.00K $15.22M 0.87%
0.87%
Reduce
43 6.68M $15.04M 0.86%
0.86%
Reduce
44 812.65K $14.75M 0.85%
0.85%
Reduce
45 1.05M $13.77M 0.79%
0.79%
Hold
46 60.25K $13.49M 0.77%
0.77%
Reduce
47 520.80K $12.51M 0.72%
0.72%
Add
48 58.80K $12.05M 0.69%
0.69%
New
49 536.11K $10.97M 0.63%
0.63%
Reduce
50 159.30K $10.17M 0.58%
0.58%
Reduce

FAQ

What did Rock Springs Capital Management LP buy in 2025-Q1?

In its 2025-Q1 13F filing, Rock Springs Capital Management LP reported 95 equity positions worth $1.74B in aggregate; its largest disclosed positions were ARGX ($104.02M), LLY ($93.74M), BPMC ($89.18M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $1.74B of long equity holdings across 95 positions as of 2025-Q1. Top-10 holdings account for 36.7% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →